2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
13
Neoplasms
5
Myelodysplastic Syndromes
5
Carcinoma, Non-Small-Cell Lung
4
Multiple Myeloma
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Leukemia, Myelomonocytic, Chronic
3
Hematologic Neoplasms
3
Urinary Bladder Neoplasms
2
Recurrence
2
Pathologic Complete Response
2
Ovarian Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Lung Neoplasms
2
Hodgkin Disease
2
Breast Neoplasms
2
Tumor Virus Infections
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Sarcoma
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmacytoma
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Interventions
durvalumab
1
cc-486
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Microsatellite Stable Colorectal Carcinoma
×
cc-486
×
Clear all
NCT02811497
2021-04-01
METADUR
University Health Network, Toronto
Phase 2
Completed
28 enrolled